Kaiser Permanente Washington Health Research Institute Doses First Patient for COVID-19 Vaccine with Moderna’s mRNA-1273

Kaiser Permanente Washington Health Research Institute Doses First Patient for COVID-19 Vaccine with Moderna’s mRNA-1273

A Phase I clinical trial evaluating Moderna’s mRNA-1273 to fight against COVID-19 commenced at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle—the clinical investigational site was able to dose the first patient. The National Institute of...
Top Investigator from John Theurer Cancer Center, Hackensack University Medical Center to Study Gene-Therapy Cancer Vaccine in Phase II Trial

Top Investigator from John Theurer Cancer Center, Hackensack University Medical Center to Study Gene-Therapy Cancer Vaccine in Phase II Trial

The John Theurer Cancer Center, Hackensack University Medical Center reports they are the only clinical investigational site in New Jersey—and the only one of just 17 sites around America—participating in a multicenter international Phase II study on an innovative...

Pin It on Pinterest